ArticleAnnals of medicine and surgery (2012)2026
Adenomyosis with abnormal uterine bleeding complicated by venous thrombosis: a case series and literature review.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adenomyosis is a benign disease characterized by the invasion of endometrial glands and stroma into the uterine myometrium, commonly presenting with abnormal uterine bleeding. Methods: This paper retrospectively analyzes three cases of adenomyosis complicated by venous thromboembolism (VTE) in patients hospitalized at our hospital from 2023 to 2025, and discusses its high-risk factors and treatment strategies in combination with the literature review. Inclusion criteria: patients diagnosed with adenomyosis and having a history of menorrhagia complicated by venous thromboembolism. Exclusion criteria: VTE caused by other diseases; patients in menopause. Result: Case 1 involved a 47-year-old female who developed thrombosis in the right basilic vein after laparoscopic total hysterectomy. Case 2 was a 47-year-old female who experienced lower extremity venous thrombosis following treatment with gonadotropin-releasing hormone agonists (GnRH-a) combined with a levonorgestrel-releasing intrauterine system. Case 3 was a 49-year-old female who developed portal vein, splenic vein, and superior mesenteric vein thrombosis after long-term norethisterone therapy. Clinical experience indicates that GnRH-a combined with dienogest (DNG) can effectively control symptoms and preserve the uterus, but thrombotic risks require vigilance. Through case analysis and literature review, this article emphasizes the importance of individualized treatment plans. Conclusion: Patients with adenomyosis presenting with an enlarged uterus and menorrhagia are prone to developing VTE. When VTE occurs, total hysterectomy is often selected as the treatment. We attempted a combined regimen of GnRH-a, DNG, and anticoagulant therapy, which was effective in one case.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.